Home

Medtronic (MDT)

93.03
-1.27 (-1.35%)

Medtronic is a global leader in medical technology, focused on developing and providing innovative therapeutic solutions to improve the lives of patients

The company specializes in a wide range of medical devices and therapies, addressing conditions in areas such as diabetes care, cardiovascular health, surgical innovations, and neurological disorders. Medtronic is committed to advancing healthcare through cutting-edge research, collaboration with healthcare providers, and a strong emphasis on patient-centered care, aiming to enhance the quality of life for millions around the world.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close94.30
Open94.75
Bid93.10
Ask94.44
Day's Range92.95 - 95.57
52 Week Range75.96 - 94.93
Volume7,639,409
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield2.800 (3.01%)
1 Month Average Volume7,195,303

News & Press Releases

This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesdaybenzinga.com
Via Benzinga · March 4, 2025
Analyst Expectations For Medtronic's Futurebenzinga.com
Via Benzinga · March 4, 2025
MEDTRONIC PLC (NYSE:MDT) is setting up nicely for a breakout.chartmill.com
MEDTRONIC PLC (NYSEMDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know.
Via Chartmill · February 27, 2025
Medtronic Stock Gets IBD Rating Liftinvestors.com
In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier.
Via Investor's Business Daily · February 25, 2025
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Streamfool.com
Via The Motley Fool · February 24, 2025
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patientsbenzinga.com
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.
Via Benzinga · February 24, 2025
Is Medtronic Stock a Buy?fool.com
The medical device maker has been a huge winner for its long-term shareholders.
Via The Motley Fool · February 21, 2025
Why Medtronic Stock Is Sinking Todayfool.com
Via The Motley Fool · February 18, 2025
Why Medtronic Just Undercut Its Buy Zone With A 5% Dropinvestors.com
The company reported fiscal third-quarter earnings and, on at least one metric, disappointed investors.
Via Investor's Business Daily · February 18, 2025
MarketBeat Week in Review – 02/17 - 02/21
Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news
Via MarketBeat · February 22, 2025
Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.
Via MarketBeat · February 21, 2025
The Smartest Dividend Stocks to Buy With $1,000 Right Nowfool.com
Via The Motley Fool · February 20, 2025
Medtronic Logs Worst Day In Nearly 5 Years On Q3 Revenue Miss, But Retail Goes Bargain Huntingstocktwits.com
The company said its medical-surgical segment struggled with ongoing stapling market pressures and temporary shifts in U.S. distributor buying patterns.
Via Stocktwits · February 18, 2025
Medtronic Unusual Options Activity For February 14benzinga.com
Via Benzinga · February 14, 2025
Medtronic (MDT) Q3 2025 Earnings Call Transcriptfool.com
MDT earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 18, 2025
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · February 18, 2025
Stay informed with the top movers within the S&P500 index on Tuesday.chartmill.com
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · February 18, 2025
Which S&P500 stocks are gapping on Tuesday?chartmill.com
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · February 18, 2025
US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?benzinga.com
Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday.
Via Benzinga · February 18, 2025
Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecastbenzinga.com
Medtronic reported Q3 revenue of $8.29 billion, missing estimates, while EPS of $1.39 topped forecasts. The company reaffirmed its FY25 organic growth guidance.
Via Benzinga · February 18, 2025
US Stocks Likely To Open Higher Amid Ukraine Peace Talk Hopes As Russian, American Officials Meetbenzinga.com
U.S. stock futures rose on Tuesday following a mixed close on Friday after the Presidents' Day holiday on Monday.
Via Benzinga · February 18, 2025
Earnings Scheduled For February 18, 2025benzinga.com
Via Benzinga · February 18, 2025
Dow Dips Over 150 Points, But Records Weekly Gain: Investor Sentiment Improves, Greed Index In 'Fear' Zonebenzinga.com
Via Benzinga · February 18, 2025
Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesdaybenzinga.com
Via Benzinga · February 18, 2025
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loombenzinga.com
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.
Via Benzinga · February 14, 2025